{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Emergency Management of Malignancy-Associated Hypercalcemia

Purpose of Activity

To provide an overview of the care needed by patients with malignancy-associated hypercalcemia (MAH) presenting in the emergency department (ED).

Learning Objectives/Outcomes

After completing this continuing education activity you will be able to:

  1. Describe the clinical presentation and risks associated with MAH.
  2. Explain the treatment options for managing patients with MAH in the ED.
Price: $24.95

Credits:

  • ANCC 2.5 CH / 1.0 APH
  • DC - BON 2.5 CH
  • FL - BON 2.5 CH
  • GA - BON 2.5 CH

Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, #50-1223, Florida Board of Nursing, #50-1223, and Georgia Board of Nursing, #50-1223. Your certificate is valid in all states.

Awarded Advanced Pharmacology Hours







Test Code: AENJ0116
Published: Jan/Mar 2016
Expires: 3/5/2021
Passing Score: 13/18 (72%)
Authors: Bethany Dellay, PharmD; Meghan Groth, PharmD, BCPS